Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes

Journal of Thrombosis and Thrombolysis

Volumn 30, Issue 1, 2010, Pages 10-13

  Ray, Kausik K ^a   Nazer, Babak ^b   Cairns, Richard ^c   Michael Gibson, C ^d   Cannon, Christopher P ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Worldwide Clinical Trials   (United Kingdom)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Acute coronary syndromes; C reactive protein; Inflammation; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; C REACTIVE PROTEIN; CLOPIDOGREL; GATIFLOXACIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; PRAVASTATIN; TRIACYLGLYCEROL; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MALE; MEDICAL HISTORY; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; ATHEROSCLEROSIS; COMPLICATION; CONTROLLED CLINICAL TRIAL; INFLAMMATION; MIDDLE AGED; OBSERVATION; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; MALE; MIDDLE AGED; OBSERVATION; PRAVASTATIN; PYRROLES; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77953872891     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-010-0463-7     Document Type: Article

References (14)

1. CP Cannon WS Weintraub LA Demopoulos R Vicari MJ Frey N Lakkis FJ Neumann DH Robertson PT DeLucca PM DiBattiste CM Gibson E Braunwald 2001 Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 1879 1887 10.1056/NEJM200106213442501 1:CAS:528:DC%2BD3MXltFers70%3D 11419424 (Pubitemid 32564900)
2. KA Fox P Poole-Wilson TC Clayton RA Henderson TR Shaw DJ Wheatley R Knight SJ Pocock 2005 5-Year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial Lancet 366 914 920 10.1016/S0140-6736(05)67222-4 1:STN:280:DC%2BD2MvosVehug%3D%3D 16154018 (Pubitemid 41265665)
3. DA Morrow JA de Lemos MS Sabatine SD Wiviott MA Blazing A Shui N Rifai RM Califf E Braunwald 2006 Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial Circulation 114 281 288 10.1161/CIRCULATIONAHA.106.628909 1:CAS:528:DC%2BD28XntVSms70%3D 16847150 (Pubitemid 44297094)
4. J Chamberlain J Gunn S Francis C Holt D Crossman 1999 Temporal and spatial distribution of interleukin-1 beta in balloon injured porcine coronary arteries Cardiovasc Res 44 156 165 10.1016/S0008-6363(99)00175-3 1:CAS:528:DyaK1MXmtVyis7k%3D 10615399 (Pubitemid 29431693)
5. AW Chan, et al. 2003 Relation of inflammation and benefit of statins after percutaneous coronary interventions Circulation 107 1750 1756 10.1161/01.CIR.0000060541.18923.E9 1:CAS:528:DC%2BD3sXisFaju7w%3D 12665489 (Pubitemid 36418355)
6. A Gaspardone F Versaci I Proietti F Tomai L Altamura O Skossyreva L Chiariello 2002 Effect of atorvastatin (80 mg) initiated at the time of coronary artery stent implantation on C-reactive protein and six-month clinical events Am J Cardiol 90 786 789 10.1016/S0002-9149(02)02615-2 1:CAS:528: DC%2BD38XnsVaitrc%3D 12356402 (Pubitemid 35279408)
7. AW Bonz B Lengenfelder M Jacobs J Strotmann S Held G Ertl W Voelker 2003 Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism Am J Heart 145 693 699 10.1067/mhj.2003.65 1:CAS:528:DC%2BD3sXivV2nt7w%3D (Pubitemid 36403500)
8. M Almagor A Keren S Banai 2003 Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease Am Heart J 145 248 253 10.1067/mhj.2003.16 1:CAS:528:DC%2BD3sXjtVartrw%3D 12595841 (Pubitemid 36207945)
9. AM Lincoff DJ Kereiakes MA Mascelli, et al. 2001 Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization Circulation 104 163 167 1:CAS:528:DC%2BD3MXlvVKktb8%3D 11447080
10. CP Cannon E Braunwald CH McCabe DJ Rader JL Rouleau R Belder SV Joyal KA Hill MA Pfeffer AM Skene 2004 Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 1495 1504 10.1056/NEJMoa040583 1:CAS:528:DC%2BD2cXjtVeqtr8%3D 15007110 (Pubitemid 38477774)
11. PM Ridker CP Cannon D Morrow N Rifai LM Rose CH McCabe MA Pfeffer E Braunwald The Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators 2005 C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 20 28 10.1056/NEJMoa042378 1:CAS:528:DC%2BD2MXis12msA%3D%3D 15635109 (Pubitemid 40075677)
12. AS Kini P Lee JD Marmur A Agarwal ME Duffy MC Kim SK Sharma 2004 Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality Am J Cardiol 93 18 23 10.1016/j.amjcard.2003.09.006 1:CAS:528:DC%2BD3sXpvF2ru7o%3D 14697460 (Pubitemid 38022028)
13. KK Ray CP Cannon CH McCabe R Cairns AM Tonkin FM Sacks G Jackson E Braunwald 2005 Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial J Am Coll Cardiol 46 1405 1410 10.1016/j.jacc.2005.03.077 1:CAS:528:DC%2BD2MXhtFWht7zJ 16226162 (Pubitemid 41446173)
14. SD Wiviott JA de Lemos CP Cannon M Blazing SA Murphy CH McCabe R Califf E Braunwald 2006 A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22 Circulation 113 1406 1414 10.1161/CIRCULATIONAHA.105.586347 1:CAS:528:DC%2BD28Xitlegtbs%3D 16534008 (Pubitemid 43739437)